Vascular Inflammation in Hypertension: Targeting Lipid Mediators Unbalance and Nitrosative Stress
- 1 April 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Hypertension Reviews
- Vol. 17 (1) , 35-46
Abstract
: Arterial hypertension is a worldwide public health threat. High Blood Pressure (BP) is commonly associated with endothelial dysfunction, nitric oxide synthases (NOS) unbalance and high peripheral vascular resistance. In addition to those, inflammation has also been designated as one of the major components of BP increase and organ damage in hypertension. This minireview discusses vascular inflammatory triggers of high BP and aims to fill the existing gaps of antiinflammatory therapy of hypertension. Among the reasons discussed, enhanced prostaglandins rather than resolvins lipid mediators, immune cell infiltration and oxidative/nitrosative stress are pivotal players of BP increase within the inflammatory hypothesis. To address these inflammatory targets, this review also proposes new concepts in hypertension treatment with non-steroidal antiinflammatory drugs (NSAIDs), nitric oxide-releasing NSAIDs (NO-NSAIDs) and specialized proresolving mediators (SPM). In this context, the failure of NSAIDs in hypertension treatment seems to be associated with the reduction of endogenous NO bioavailability, which is not necessarily an effect of all drug members of this pharmacological class. For this reason, NO-releasing NSAIDs seem to be safer and more specific therapy to treat vascular inflammation in hypertension than regular NSAIDs.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (Finance Code 001)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-02768-17)
This publication has 110 references indexed in Scilit:
- Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertensionBMC Cardiovascular Disorders, 2012
- Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemProceedings of the National Academy of Sciences, 2012
- Upregulation of Inducible Nitric Oxide Synthase Contributes to Attenuated Cutaneous Vasodilation in Essential Hypertensive HumansHypertension, 2011
- Harmful Effects of NSAIDs among Patients with Hypertension and Coronary Artery DiseaseThe American Journal of Medicine, 2011
- Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertensionBritish Journal of Pharmacology, 2011
- Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346)British Journal of Pharmacology, 2010
- Endothelium‐dependent contractions in SHR: a tale of prostanoid TP and IP receptorsBritish Journal of Pharmacology, 2009
- Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive ratsBritish Journal of Pharmacology, 2008
- Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunctionJournal of Experimental Medicine, 2007
- Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium‐derived contracting factorBritish Journal of Pharmacology, 2007